SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.
Molecular Weight:
377.99
Purity:
0.9772
CAS Number:
[2248703-42-4]
Formula:
C20H40ClNO3
Target:
LPL Receptor|||Apoptosis|||Bcl-2 Family|||Caspase
T83653
* VAT and and shipping costs not included. Errors and price changes excepted